Literature DB >> 2235879

Biochemical and mechanical characterization of enzyme-digestible hydrogels.

W S Shalaby1, K Park.   

Abstract

Albumin-cross-linked hydrogels were prepared by free radical polymerization using 1-vinyl-2-pyrrolidinone as a monomer and functionalized albumin as a crosslinking agent. The degree of chemical cross-linking was controlled by varying the degree of albumin functionality and the concentration of albumin. With emphasis placed on the potential use of these hydrogels for long-term oral drug delivery, gel characterization studies examined both the swelling and the mechanical properties in the absence and presence of pepsin. In the absence of pepsin, the equilibrium swelling ratio in simulated gastric fluid ranged from 17 to 55, depending on the degree of albumin functionality and the albumin concentration. Swelling was pH dependent at pH's greater than 7. The uptake of solvent into the dried hydrogels was determined to be Fickian. The integrity of swelling gels was dependent on the concentration of the functionalized albumin as well as on the degree of albumin functionality. In the presence of pepsin, a predominance of either surface or bulk degradation was observed, depending on the functionality of the albumin used as a cross-linker. Gel integrity during pepsin degradation also showed a marked dependence on the albumin functionality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235879     DOI: 10.1023/a:1015956714669

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  The effect of density on the gastric emptying of single- and multiple-unit dosage forms.

Authors:  S S Davis; A F Stockwell; M J Taylor; J G Hardy; D R Whalley; C G Wilson; H Bechgaard; F N Christensen
Journal:  Pharm Res       Date:  1986-08       Impact factor: 4.200

2.  Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets.

Authors:  H Bechgaard; K Ladefoged
Journal:  J Pharm Pharmacol       Date:  1978-11       Impact factor: 3.765

3.  Measurement of gastric functions during digestion of ordinary solid meals in man.

Authors:  J R Malagelada; G F Longstreth; W H Summerskill; V L Go
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Gastric emptying of large single unit dosage forms.

Authors:  S S Davis; F Norring-Christensen; R Khosla; L C Feely
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

Review 6.  The physiology and pathophysiology of gastric emptying in humans.

Authors:  H Minami; R W McCallum
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

7.  Gastric emptying of enteric-coated tablets.

Authors:  H M Park; S M Chernish; B D Rosenek; R L Brunelle; B Hargrove; H N Wellman
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

8.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

9.  The principles of enzyme stabilization. IV. Modification of 'key' functional groups in the tertiary structure of proteins.

Authors:  V P Torchilin; A V Maksimenko; V N Smirnov; I V Berezin; A M Klibanov; K Martinek
Journal:  Biochim Biophys Acta       Date:  1979-03-16

10.  Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers.

Authors:  H S Ch'ng; H Park; P Kelly; J R Robinson
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

View more
  4 in total

1.  Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans.

Authors:  Eytan A Klausner; Eran Lavy; Miklos Barta; Eva Cserepes; Michael Friedman; Amnon Hoffman
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.

Authors:  Eytan A Klausner; Eran Lavy; David Stepensky; Michael Friedman; Amnon Hoffman
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

4.  Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation.

Authors:  H Brøndsted; J Kopecek
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.